These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 790952)

  • 41. A comparison of the accuracy of a least squares regression, a Bayesian, Chiou's and the steady-state clearance method of individualising theophylline dosage.
    Hurley SF; McNeil JJ
    Clin Pharmacokinet; 1988 May; 14(5):311-20. PubMed ID: 3396259
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effectiveness of drug level monitoring and pharmacokinetics in individualizing theophylline therapy.
    Fitzpatrick RW; Moss-Barclay C
    J Clin Hosp Pharm; 1985 Sep; 10(3):279-87. PubMed ID: 4066978
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Theophylline clearance: effect of marked obesity.
    Blouin RA; Elgert JF; Bauer LA
    Clin Pharmacol Ther; 1980 Nov; 28(5):619-23. PubMed ID: 7438680
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The disposition of inhaled lysine theophylline in volunteers.
    Jackson SH; Wiffen JK; Johnston A; Peverel-Cooper CA
    Eur J Clin Pharmacol; 1984; 26(5):635-7. PubMed ID: 6468482
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hypothesis for the individualisation of drug dosage.
    Koup JR; Sack CM; Smith AL; Gibaldi M
    Clin Pharmacokinet; 1979; 4(6):460-9. PubMed ID: 519932
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The relationship between clearance of theophylline and age within the adult age range.
    Jackson SH; Wiffen JK; Johnston A; Peverel-Cooper CA
    Eur J Clin Pharmacol; 1985; 29(2):177-9. PubMed ID: 3908122
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Influence of high-dose pentobarbital on theophylline pharmacokinetics: a case report.
    Gibson GA; Blouin RA; Bauer LA; Rapp RP; Tibbs PA
    Ther Drug Monit; 1985; 7(2):181-4. PubMed ID: 4024211
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Computer prediction of serum theophylline concentrations in ambulatory patients.
    Deci PA; Lopez LM; Robinson JD; Grauer K
    Ther Drug Monit; 1985; 7(4):421-5. PubMed ID: 3841237
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of the effect of variability in the volume of distribution of theophylline on the predictability of the iterative and the Chiou methods using computer simulations.
    Pancorbo S
    Ther Drug Monit; 1986; 8(3):269-73. PubMed ID: 3750368
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Saliva theophylline concentrations after a single oral dose.
    Culig J; Johnston A; Turner P
    Br J Clin Pharmacol; 1982 Feb; 13(2):243-5. PubMed ID: 7059427
    [No Abstract]   [Full Text] [Related]  

  • 51. The effect of age on theophylline clearance in normal subjects.
    Randolph WC; Seaman JJ; Dickson B; Peace KE; Frank WO; Young MD
    Br J Clin Pharmacol; 1986 Nov; 22(5):603-5. PubMed ID: 3790407
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Influence of continuous gastric suction on theophylline clearance in a newborn.
    Boer HR; Gal P
    Dev Pharmacol Ther; 1985; 8(5):280-3. PubMed ID: 4042793
    [No Abstract]   [Full Text] [Related]  

  • 53. Theophylline pharmacotherapy.
    Baptista RJ; Driscoll DF
    Am Pharm; 1984 May; NS24(5):57-65. PubMed ID: 6731287
    [No Abstract]   [Full Text] [Related]  

  • 54. [Not Available].
    Matte J; Lapointe M; Lebel M
    Can Fam Physician; 1982 Jan; 28():111-5. PubMed ID: 21289851
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Therapeutic Drug Monitoring (TDM) Implementation in Public Hospitals in Greece in 2003 and 2021: A Comparative Analysis of TDM Evolution over the Years.
    Voulgaridou G; Paraskeva T; Ragia G; Atzemian N; Portokallidou K; Kolios G; Arvanitidis K; Manolopoulos VG
    Pharmaceutics; 2023 Aug; 15(9):. PubMed ID: 37765152
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Protein kinase A enhances lipopolysaccharide-induced IL-6, IL-8, and PGE₂ production by human gingival fibroblasts.
    Ara T; Fujinami Y; Urano H; Hirai K; Hatori T; Miyazawa H
    J Negat Results Biomed; 2012 Mar; 11():10. PubMed ID: 22452847
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacokinetic optimisation of asthma treatment.
    Taburet AM; Schmit B
    Clin Pharmacokinet; 1994 May; 26(5):396-418. PubMed ID: 7914480
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Individualized aminophylline therapy in patients with obstructive airway disease: oral dosage prediction from an intravenous test dose.
    Horai Y; Ishizaki T; Sasaki T; Watanabe M; Kabe J
    Eur J Clin Pharmacol; 1982; 23(2):111-21. PubMed ID: 7140800
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Individualizing theophylline dosage: evaluation of a single-point maintenance dose prediction method.
    Wilkens JH; Neuenkirchen H; Sybrecht GW; Oellerich M
    Eur J Clin Pharmacol; 1984; 26(4):491-8. PubMed ID: 6734708
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A critique of dosing strategies for beta-2 adrenergic agents and theophylline.
    Jenne JW
    Lung; 1981; 159(6):295-314. PubMed ID: 6117677
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.